SIX •
Healthcare •
Biotechnology •
Quote as of 07/01/2026 17:30
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeSIX
Market Capitalization31.52 mln
Float37.20 mln
1-Year Forecast
2.73
Transformational upside
Relative Strength
6
/ 100
Severely lagging
Debt / Equity
0.05
Debt-free
ROE
-51.56
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Founded in 2025 and headquartered in Lausanne, Switzerland, MindMaze Therapeutics builds technology designed to help patients with neurological conditions. The company combines brain science with digital treatment tools to tackle serious and widespread health problems in the field of neurology.
